Shares of WELL Health Technologies Corp. (TSE:WELL - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the seven brokerages that are presently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is C$7.39.
WELL has been the topic of several recent research reports. CIBC cut shares of WELL Health Technologies from an "outperform" rating to a "neutral" rating and decreased their target price for the company from C$5.50 to C$4.75 in a research report on Monday, January 22nd. Pi Financial upped their target price on shares of WELL Health Technologies from C$8.25 to C$8.50 in a research note on Wednesday, January 31st. Finally, Royal Bank of Canada set a C$5.50 target price on shares of WELL Health Technologies and gave the stock an "outperform" rating in a research note on Tuesday, February 6th.
View Our Latest Stock Report on WELL Health Technologies
WELL Health Technologies Price Performance
Shares of WELL traded down C$0.07 during midday trading on Friday, hitting C$3.62. 716,745 shares of the company traded hands, compared to its average volume of 982,531. The firm has a 50 day moving average of C$3.84 and a 200-day moving average of C$3.89. WELL Health Technologies has a 52 week low of C$3.58 and a 52 week high of C$5.94. The stock has a market cap of C$889.18 million, a price-to-earnings ratio of -185.00, a PEG ratio of -1.93 and a beta of 1.27. The company has a debt-to-equity ratio of 50.38, a quick ratio of 1.02 and a current ratio of 1.15.
About WELL Health Technologies
(
Get Free ReportWELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.
See Also
Before you consider WELL Health Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and WELL Health Technologies wasn't on the list.
While WELL Health Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
